Reference
Lopez Ruiz R, et al. Long-term immune-related adverse events after alemtuzumab. Multiple Sclerosis Journal 27 (Suppl.): 625-626 abstr. P746, No. 2, 12 Oct 2021. Available from: URL: http://doi.org/10.1177/13524585211044667 [abstract]
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1882, 32 (2021). https://doi.org/10.1007/s40278-021-05499-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-05499-3